Merck's new injectable cancer drug, Keytruda Qlex, promises to transform patient treatment with a quick administration time and flexible dosing, all while maintaining effectiveness. Available in late September, this shift is critical as the market braces for biosimilar competition.
A recent study reveals that high sucralose intake may hinder immunotherapy effectiveness in cancer patients. Discover how arginine supplements could be the key to improving outcomes.
The World Health Organization has released its updated Essential Medicines Lists, adding crucial cancer and diabetes treatments, aiming to improve global health access.
A groundbreaking study reveals that a new mRNA vaccine can activate the immune system and significantly shrink tumors in mice, sparking hope for a universal cancer vaccine that could revolutionize treatment methods.
A groundbreaking study from the University of Florida reveals that a new mRNA vaccine could trigger a powerful immune response against various cancers, offering hope for treatment-resistant tumors. Researchers found that this approach might lead to a universal cancer vaccine that could complement existing therapies.
A stunning study reveals prescribed exercise may outperform chemotherapy for colon cancer survivors, sparking excitement at the ASCO annual meeting. AstraZeneca also showcases groundbreaking immunotherapy advancements!
A groundbreaking study reveals that immunotherapy drug dostarlimab has led to remarkable tumor disappearance in cancer patients, offering a new hope for those battling solid tumors.
Eva Brinley, a 72-year-old traveler, faced a colon cancer diagnosis after a routine colonoscopy. Opting for immunotherapy over chemotherapy, she shares her inspiring journey to remission and the importance of regular health checkups.
